arginine vasopressin has been researched along with Bone Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunck, M; Frank, E; Holsboer, F; Landgraf, R; Murgatroyd, C; Singewald, N; Spengler, D; Wigger, A | 1 |
1 other study(ies) available for arginine vasopressin and Bone Cancer
| Article | Year |
|---|---|
Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety.
Topics: Alleles; Animals; Anxiety; Arginine Vasopressin; Bone Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; DNA-Binding Proteins; DNA, Single-Stranded; Exploratory Behavior; Fear; Gene Expression Regulation; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Inbreeding; Maze Learning; Osteosarcoma; Oxytocin; Paraventricular Hypothalamic Nucleus; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Protein Binding; Protein Interaction Mapping; Rats; Rats, Wistar; Reaction Time; Recombinant Fusion Proteins; Repressor Proteins; Ribonucleoproteins; Transcription Factors; Transcription, Genetic; Transfection | 2004 |